Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$43.76 - $68.97 $437,600 - $689,700
10,000 New
10,000 $479,000
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $283,632 - $367,704
-2,400 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $3.16 Million - $4.09 Million
-26,700 Reduced 91.75%
2,400 $361,000
Q3 2021

Nov 15, 2021

BUY
$93.51 - $129.4 $2.72 Million - $3.77 Million
29,100 New
29,100 $3.47 Million
Q1 2021

May 14, 2021

SELL
$81.28 - $104.34 $16,256 - $20,868
-200 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$81.28 - $104.34 $4.02 Million - $5.15 Million
-49,400 Reduced 99.6%
200 $18,000
Q4 2020

Feb 16, 2021

SELL
$86.4 - $121.75 $17.6 Million - $24.8 Million
-204,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$86.4 - $121.75 $4.29 Million - $6.04 Million
49,600 New
49,600 $4.74 Million
Q3 2020

Nov 13, 2020

BUY
$95.43 - $116.09 $15.1 Million - $18.4 Million
158,300 Added 346.39%
204,000 $23.2 Million
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $1.39 Million - $2.29 Million
23,100 Added 102.21%
45,700 $4.53 Million
Q1 2020

May 15, 2020

BUY
$47.37 - $90.04 $251,061 - $477,212
5,300 Added 30.64%
22,600 $1.45 Million
Q4 2019

Feb 14, 2020

SELL
$53.13 - $71.19 $6.13 Million - $8.22 Million
-115,400 Reduced 86.96%
17,300 $1.03 Million
Q3 2019

Nov 14, 2019

BUY
$57.11 - $73.3 $4.81 Million - $6.18 Million
84,300 Added 174.17%
132,700 $7.83 Million
Q2 2019

Aug 14, 2019

BUY
$54.41 - $71.7 $805,268 - $1.06 Million
14,800 Added 44.05%
48,400 $3.12 Million
Q1 2019

May 15, 2019

BUY
$32.25 - $73.56 $1.08 Million - $2.47 Million
33,600 New
33,600 $2.13 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.11B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.